Anticancer and Antibacterial Activeness of Fused Pyrimidines: Newfangled Updates

被引:1
|
作者
Bhatnagar, Ayushi [1 ]
Pemawat, Gangotri [1 ]
机构
[1] Mohanlal Sukhadia Univ, Univ Coll Sci, Dept Chem, Udaipur 313001, Rajasthan, India
关键词
Fused analogues; Pyrimidine derivatives; Thienopyrimidines; Pyrazolopyrimidines; Pyridopyrimidines; Pyrimidopyrimidines; Anticancer; Antibacterial; THIENOPYRIMIDINE DERIVATIVES; ANTIPROLIFERATIVE ACTIVITY; INHIBITORS; DESIGN; APOPTOSIS; DOCKING; STRESS; POTENT; AGENTS;
D O I
10.1016/j.bioorg.2024.107780
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pyrimidine-based heterocyclic compounds are garnering substantial interest due to their essential role as a class of natural and synthetic molecules. These compounds show a diverse array of biologically relevant activities, making them highly prospective candidates for clinical translation as therapeutic agents in combating various diseases. Pyrimidine derivatives and their fused analogues, such as thienopyrimidines, pyrazolopyrimidines, pyridopyrimidines, and pyrimidopyrimidines, hold immense possibility in both anticancer and antibacterial research. These compounds exhibit notable efficacy by targeting protein kinases, which are crucial enzymes regulating fundamental cellular processes like metabolism, migration, division, and growth. Through enzyme inhibition, these derivatives disrupt key cellular signaling pathways, thereby affecting critical cellular functions and viability. The advantage lies in the ubiquity of the pyrimidine structure across various natural compounds, enabling interactions with enzymes, genetic material, and cellular components pivotal for chemical and biological processes. This interaction plays a central role in modulating vital biological activities, making pyrimidine-containing compounds indispensable in drug discovery. In the realm of anticancer therapy, these compounds strategically target key proteins like EGFR, important for aberrant cell growth. Fused pyrimidine motifs, exemplified by various drugs, are designed to inhibit EGFR, thereby impeding tumor progression. Moreover, these compounds influence potent antibacterial activity, interfering with microbial growth through mechanisms ranging from DNA replication inhibition to other vital cellular functions. This dual activity, targeting both cancer cells and microbial pathogens, underscores the versatility and potential of pyrimidine derivatives in medical applications. This review provides insights into the structural characteristics, synthesis methods, and significant medicinal applications of fused pyrimidine derivatives, highlighting their double role in combating cancer and bacterial infections.
引用
收藏
页数:28
相关论文
共 50 条
  • [21] Novel Fused Pyrimidines as Potent Cyclin-Dependent Kinases Inhibitor for Gastric Adenocarcinoma: Combined In Vitro, In Silico Anticancer Studies
    Saravanakumar, Natarajan
    Poorani, Arunagiri Sivanesan Aruna
    Dhanabalan, Anantha Krishnan
    Sugapriya, Selvam
    Kumaresan, Ganesan
    Suresh, Palaniswamy
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 104 (05)
  • [22] CHEMOTHERAPEUTIC-AGENTS .12. SYNTHESIS OF PYRIMIDINES AND FUSED PYRIMIDINES AS LEISHMANICIDES AND HERBICIDES
    RAM, VJ
    JOURNAL FUR PRAKTISCHE CHEMIE, 1989, 331 (06): : 893 - 905
  • [23] FUSED PYRIMIDINES .5. METHYLATED PYRIMIDO[4,5-D]PYRIMIDINES
    DELIA, TJ
    BAUMANN, M
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 1991, 28 (06) : 1553 - 1556
  • [24] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SOME 4-SUBSTITUTED PYRIMIDINES AND FUSED PYRIMIDINES
    ELBAHAIE, S
    ELDEEB, A
    ASSY, MC
    PHARMAZIE, 1991, 46 (01): : 26 - 28
  • [25] Recent updates of fluoroquinolones as antibacterial agents
    Ezelarab, Hend A. A.
    Abbas, Samar H.
    Hassan, Heba A.
    Abuo-Rahma, Gamal El-Din A.
    ARCHIV DER PHARMAZIE, 2018, 351 (09)
  • [26] Identification of fused pyrimidines as interleukin 17 secretion inhibitors
    Reiersolmoen, Ann Christin
    Han, Jin
    Sundby, Eirik
    Hoff, Bard Helge
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 562 - 578
  • [27] Synthesis of fused pyrimidines from amines and cyclic β-formylesters
    Toche, Raghunath B.
    Ghotekar, Bhausaheb K.
    Kazi, Muddassar A.
    Kendre, Dhananjay B.
    Jachak, Madhukar N.
    TETRAHEDRON, 2007, 63 (34) : 8157 - 8163
  • [28] In silico and in vitro evaluation of newly synthesized pyrazolo-pyridine fused tetrazolo-pyrimidines derivatives as potential anticancer and antimicrobial agents
    Patel, Harsh C.
    Patel, Manan S.
    Parekh, Jaydeepkumar N.
    Chudasama, Dipakkumar D.
    Dalwadi, Priyanka
    Kunjadiya, Anju
    Bhatt, Vaibhav
    Modi, Krunal M.
    Patel, Chirag N.
    Ram, Kesur R.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (07): : 3467 - 3490
  • [29] Updates on the versatile quinoline heterocycles as anticancer agents
    Matada, Basavarajaiah Suliphuldevara
    Yernale, Nagesh Gunavanthrao
    Basha, Jeelan N.
    PHYSICAL SCIENCES REVIEWS, 2021, : 2243 - 2259
  • [30] Recent updates on thienopyrimidine derivatives as anticancer agents
    Menna Tallah M. Sayed
    Rasha A. Hassan
    Peter A. Halim
    Afaf K. El-Ansary
    Medicinal Chemistry Research, 2023, 32 : 659 - 681